← Back to Clinical Trials
Recruiting NCT00655096

NCT00655096 Screening for Research Participants

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT00655096
Status Recruiting
Phase
Sponsor National Eye Institute (NEI)
Condition Eye Diseases
Study Type OBSERVATIONAL
Enrollment 10,000 participants
Start Date 2008-08-20
Primary Completion

Trial Parameters

Condition Eye Diseases
Sponsor National Eye Institute (NEI)
Study Type OBSERVATIONAL
Phase N/A
Enrollment 10,000
Sex ALL
Min Age 2 Years
Max Age 100 Years
Start Date 2008-08-20
Completion N/A

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study will allow National Eye Institute (NEI) doctors the opportunity to examine people with eye disease, whether the diagnosis is known or not, to determine if they are eligible for other NEI research studies. No treatment is offered in this study. People of all ages with various eye conditions, including genetic conditions, eye movement disorders, inflammatory eye diseases, retinal diseases and external eye diseases, may be eligible for this study. Participants undergo various tests and procedures to diagnose or evaluate their eye disease. The procedures may include the following: * Personal and family medical history * Physical examination and blood tests, including genetic testing. * Eye examination with dilation to measure visual acuity and eye pressure and to examine the front and back parts of the eye. * Questionnaire about vision and daily activities. * Conjunctival swab or lacrimal bland biopsy, or both: A sample of cells from the eyes is collected by swabbing the surface of the eye or by surgically removing a small sample of the surface of the eye or tear gland. * Electroretinogram to examine retinal function: The subject sits in the dark with his or her eyes patched for 30 minutes. The patches are removed, the surface of the eyes is numbed, and contact lenses that can sense signals from the retina are placed on the eyes. The subject then watches flashing lights. * Fluorescein angiography to examine the blood vessels in the eye: A dye is injected into a vein in the arm. The dye travels through the veins to the blood vessels in the eyes. A camera takes pictures of the dye as it flows through the blood vessels. * Optical coherence tomography to measure retinal thickness: A machine used to examine the eyes produces cross-sectional pictures of the retina. * Microperimetry to test how sensitive different parts of the retina are to changing levels of light. The subject sits in front of a computer and presses a button when he or she sees a light on the screen. * Oculography to record eye movements: Eye movements are measured by contact lenses or goggles that the subject wears while watching a series of spots on a computer screen.

Eligibility Criteria

* INCLUSION CRITERIA: Participants will be able to enroll if they: * Have a diagnosed ocular disease/disorder; OR * Potentially have an unusual, interesting, or unknown ocular condition that requires the establishment of a diagnosis; OR * Potentially participate as a disease-free control participant in an NEI clinical research study; OR * Are an unaffected first-degree relative of a participant with either a diagnosed or undiagnosed ocular disorder; AND * Have the ability to understand and sign an informed consent OR if they are minor children have a legal parent/guardian with the ability to do the same. * Adults with impaired capacity to consent must have a Legally Authorized Representative (LAR) who is able to provide informed consent. EXCLUSION CRITERIA: Participants will be unable to enroll if they: * Are unwilling or unable to cooperate with the study procedures. * Female participants of childbearing potential who are pregnant are not eligible for enrollment.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology